Dilated cardiomyopathy trials in Netherlands

In Netherlands 8 Also abroad 66

8 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 13 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
A Study of the Long-term Safety and Efficacy of Danicamtiv in Adults with Symptomatic Genetic and Familial Dilated Cardiomyopathy (KINSHIP-OLE).
Where
Amsterdam, Maastricht, Rotterdam
Age
18 years and over
People
211 worldwide
Run by
Kardigan Inc.
See details and how to join2026-526139-20-00
Phase 2/3Taking people
A Study of the Efficacy and Safety of Danicamtiv in Participants with Symptomatic Genetic and Familial Dilated Cardiomyopathy.
Where
Amsterdam, Maastricht, Rotterdam
Age
18 years and over
People
230 worldwide
Run by
Kardigan Inc.
See details and how to join2025-522553-19-00
Phase 2/3Taking people
A Study of the Efficacy and Safety of Danicamtiv in Participants With Symptomatic Genetic and Familial Dilated Cardiomyopathy
Where
Amsterdam, Maastricht, Rotterdam
Age
18 years and over
People
332 worldwide
Run by
Kardigan, Inc.
See details and how to joinNCT07210723
Phase 3Taking people
A Study of the Long-term Safety and Efficacy of Danicamtiv in Adults With Symptomatic Genetic and Familial Dilated Cardiomyopathy
Where
Amsterdam, Maastricht, Rotterdam
Age
18 years and over
People
332 worldwide
Run by
Kardigan, Inc.
See details and how to joinNCT07771465
Phase 1Taking people
A Study of AZD4063 in PLN R14del Dilated Cardiomyopathy
Where
Amsterdam, Groningen, Rotterdam, Utrecht
Age
18 years to 80 years
People
23
Run by
AstraZeneca
See details and how to joinNCT07241104
Phase 1Taking people
A trial to learn how safe AZD4063 is, how it moves throughout the body over time, and how it affects the levels of PLN mRNA in adults with dilated cardiomyopathy because of an R14del mutation in the PLN gene
Where
Amsterdam, Groningen, Rotterdam, Utrecht
Age
18 years and over
People
23
Run by
AstraZeneca AB
See details and how to join2025-522002-20-00
No phaseNot yet taking people in Netherlands
Dilated Cardiomyopathy - Unknown Therapeutic Risk Reduction by Contempary Medication and Implantable Cardioverter-Defibrillators (DUTCH-ICD)
Where
Groningen, Nijmegen
Age
18 years and over
People
720
Run by
University Medical Center Groningen
See details and how to joinNCT07415642
Phase 3Taking people
Early Treatment With Candesartan vs Placebo in Genetic Carriers of Dilated Cardiomyopathy (EARLY-GENE Trial)
Where
Amsterdam, Maastricht, Rotterdam
Age
18 years to 64 years
People
320 worldwide
Run by
Cristina Avendaño Solá
See details and how to joinNCT05321875 · EU 2023-507029-40-00